Bortezomib and HDAC inhibitor PCI24781 show synergistic activity in neuroblastoma in vitro and in vivo models, inducing ROS and depressing MYCN

Currier E, Illenye S, Libous J, Bond J, Lescault P, Saulnier Sholler G.  Bortezomib and HDAC inhibitor PCI24781 show synergistic activity in neuroblastoma in vitro and in vivo models, inducing ROS and depressing MYCN. June 2010 Advances in Neuroblastoma (ANR), Stockholm, Sweden